URIBEL- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate capsul United States - English - NLM (National Library of Medicine)

uribel- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate capsul

star pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 120 mg - uribel ™ capsules indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of uribel ™ capsules has not been reported and due to the nature of its ingredients, abuse of uribel ™ capsules

URIN D/S- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate tabl United States - English - NLM (National Library of Medicine)

urin d/s- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate tabl

llorens pharmaceutical international division - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 81.6 mg - indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of urin d/s has not been reported and due to the nature of its ingredients, abuse of urin d/s is not expected.

URELLE- hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate tablet United States - English - NLM (National Library of Medicine)

urelle- hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate tablet

meda pharmaceuticals - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - hyoscyamine sulfate 0.12 mg - urelle® is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk - benefit should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

SPOTS AND VELVETS AQUARIUM CURE PROGRAM SALT- ethacridine lactate, gentian violet, malachite green oxalate, methylene blue kit United States - English - NLM (National Library of Medicine)

spots and velvets aquarium cure program salt- ethacridine lactate, gentian violet, malachite green oxalate, methylene blue kit

prodibio sas - gentian violet (unii: j4z741d6o5) (gentian violet cation - unii:3gvj31t6yy), malachite green oxalate (unii: gy1h9o33vu) (malachite green - unii:12058m7oro), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - gentian violet 0.05 mg in 1 ml - the simultaneous use of water treatment products may decrease the effectiveness of spots & velvets salt. do not use with another treatment. dispose od drugs not entirely used up at the respective collecting points disposal advice: after use, vials must be thrown in recyclable glass rubbish

STRESSGUARD- glutaral and methylene blue liquid United States - English - NLM (National Library of Medicine)

stressguard- glutaral and methylene blue liquid

seachem laboratories inc. - glutaral (unii: t3c89m417n) (glutaral - unii:t3c89m417n), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) -

METHYLENE BLEU LIQ 1% LIQUID Canada - English - Health Canada

methylene bleu liq 1% liquid

laboratoire atlas inc - methylene blue - liquid - 1% - methylene blue 1% - miscellaneous therapeutic agents

METHYLENE BLEU LIQ 2% LIQUID Canada - English - Health Canada

methylene bleu liq 2% liquid

laboratoire atlas inc - methylene blue - liquid - 2% - methylene blue 2% - antidotes

BLUE LIQUID GALL REMEDY Canada - English - Health Canada

blue liquid gall remedy

dr a c daniels company of canada limited - methylene blue; zinc sulfate; lead acetate; isopropyl alcohol - liquid - .0018%; .18%; .18%; 32.2% - methylene blue .0018%; zinc sulfate .18%; lead acetate .18%; isopropyl alcohol 32.2% - cattle; horses

Venlablue XL 150mg Prolonged Release Capsules, Hard Ireland - English - HPRA (Health Products Regulatory Authority)

venlablue xl 150mg prolonged release capsules, hard

bluefish pharmaceuticals ab - venlafaxine hydrochloride - prolonged-release capsule, hard - 150 milligram(s) - other antidepressants; venlafaxine

Venlablue XL 75 mg prolonged-release capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

venlablue xl 75 mg prolonged-release capsules, hard

bluefish pharmaceuticals ab - venlafaxine hydrochloride - prolonged-release capsule, hard - 75 milligram(s) - other antidepressants; venlafaxine